Compare PEB & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEB | PRGO |
|---|---|---|
| Founded | 2009 | 1887 |
| Country | United States | Ireland |
| Employees | 52 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | N/A | 2013 |
| Metric | PEB | PRGO |
|---|---|---|
| Price | $19.51 | $10.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 3 |
| Target Price | $13.30 | ★ $19.33 |
| AVG Volume (30 Days) | 2.2M | ★ 2.9M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | 0.28% | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.25 | $1.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.30 | $9.23 |
| 52 Week High | $19.93 | $24.61 |
| Indicator | PEB | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 58.43 | 54.14 |
| Support Level | $18.35 | $10.16 |
| Resistance Level | $19.76 | $11.61 |
| Average True Range (ATR) | 0.60 | 0.45 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 65.82 | 54.67 |
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,052 rooms across 44 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.